Structure

Physi-Chem Properties

Molecular Weight:  322.17
Volume:  329.529
LogP:  1.573
LogD:  1.68
LogS:  -3.513
# Rotatable Bonds:  1
TPSA:  45.06
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  7
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.807
Synthetic Accessibility Score:  6.848
Fsp3:  0.55
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.001
MDCK Permeability:  1.9901654013665393e-05
Pgp-inhibitor:  0.098
Pgp-substrate:  0.98
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.02

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.986
Plasma Protein Binding (PPB):  60.782081604003906%
Volume Distribution (VD):  2.334
Pgp-substrate:  43.475704193115234%

ADMET: Metabolism

CYP1A2-inhibitor:  0.056
CYP1A2-substrate:  0.617
CYP2C19-inhibitor:  0.037
CYP2C19-substrate:  0.948
CYP2C9-inhibitor:  0.054
CYP2C9-substrate:  0.316
CYP2D6-inhibitor:  0.473
CYP2D6-substrate:  0.893
CYP3A4-inhibitor:  0.435
CYP3A4-substrate:  0.909

ADMET: Excretion

Clearance (CL):  5.726
Half-life (T1/2):  0.183

ADMET: Toxicity

hERG Blockers:  0.686
Human Hepatotoxicity (H-HT):  0.559
Drug-inuced Liver Injury (DILI):  0.165
AMES Toxicity:  0.202
Rat Oral Acute Toxicity:  0.894
Maximum Recommended Daily Dose:  0.907
Skin Sensitization:  0.228
Carcinogencity:  0.563
Eye Corrosion:  0.003
Eye Irritation:  0.013
Respiratory Toxicity:  0.967

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC477156

Natural Product ID:  NPC477156
Common Name*:   (10R,14S,16R,17S)-15-ethenyl-13-methyl-19-oxa-3,13-diazahexacyclo[14.3.1.02,10.04,9.010,15.012,17]icosa-2,4,6,8-tetraen-14-ol
IUPAC Name:   (10R,14S,16R,17S)-15-ethenyl-13-methyl-19-oxa-3,13-diazahexacyclo[14.3.1.02,10.04,9.010,15.012,17]icosa-2,4,6,8-tetraen-14-ol
Synonyms:  
Standard InCHIKey:  SFYMRFPMSFVBLE-QAKIGQEHSA-N
Standard InCHI:  InChI=1S/C20H22N2O2/c1-3-19-13-8-16-17-20(19,12-6-4-5-7-14(12)21-17)9-15(11(13)10-24-16)22(2)18(19)23/h3-7,11,13,15-16,18,23H,1,8-10H2,2H3/t11-,13+,15?,16?,18-,19?,20-/m0/s1
SMILES:  CN1[C@H](C2([C@@H]3CC4C5=NC6=CC=CC=C6[C@@]52CC1[C@H]3CO4)C=C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   163092148
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0002497] Indoles
          • [CHEMONTID:0004196] 3-alkylindoles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. PMID[16643063]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. PMID[16989532]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. PMID[24256496]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota leaves and vine stems Xishuangbanna Tropical Botanical Garden (XTBG), Chinese Academy of Science (CAS), Mengla County, Yunnan Province, China 2009-OCT PMID[26103517]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. PMID[26222693]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21995 Gelsemium elegans Species Gelsemiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 > 25000 nM PMID[26103517]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC477156 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC477157
0.9375 High Similarity NPC116519
0.9272 High Similarity NPC477158
0.8639 High Similarity NPC243162
0.8543 High Similarity NPC472100
0.84 Intermediate Similarity NPC477155
0.816 Intermediate Similarity NPC469462
0.8052 Intermediate Similarity NPC472103
0.7716 Intermediate Similarity NPC473297
0.763 Intermediate Similarity NPC475962
0.75 Intermediate Similarity NPC264589
0.747 Intermediate Similarity NPC469461
0.7456 Intermediate Similarity NPC278887
0.7384 Intermediate Similarity NPC276993
0.7384 Intermediate Similarity NPC181138
0.7384 Intermediate Similarity NPC21752
0.7384 Intermediate Similarity NPC298851
0.7384 Intermediate Similarity NPC293255
0.7384 Intermediate Similarity NPC210415
0.7303 Intermediate Similarity NPC469460
0.7303 Intermediate Similarity NPC478079
0.7299 Intermediate Similarity NPC472122
0.7299 Intermediate Similarity NPC24594
0.7288 Intermediate Similarity NPC19679
0.7283 Intermediate Similarity NPC473880
0.7273 Intermediate Similarity NPC472105
0.7273 Intermediate Similarity NPC187827
0.7238 Intermediate Similarity NPC105055
0.7238 Intermediate Similarity NPC22689
0.7212 Intermediate Similarity NPC475763
0.7202 Intermediate Similarity NPC211525
0.7202 Intermediate Similarity NPC153694
0.7193 Intermediate Similarity NPC472106
0.7176 Intermediate Similarity NPC472121
0.7176 Intermediate Similarity NPC472101
0.7176 Intermediate Similarity NPC472120
0.7162 Intermediate Similarity NPC264580
0.716 Intermediate Similarity NPC310403
0.716 Intermediate Similarity NPC63210
0.716 Intermediate Similarity NPC97380
0.716 Intermediate Similarity NPC263709
0.716 Intermediate Similarity NPC243673
0.716 Intermediate Similarity NPC148468
0.7134 Intermediate Similarity NPC212799
0.7111 Intermediate Similarity NPC52262
0.7095 Intermediate Similarity NPC472110
0.7095 Intermediate Similarity NPC139291
0.7095 Intermediate Similarity NPC472108
0.7095 Intermediate Similarity NPC472109
0.7093 Intermediate Similarity NPC475420
0.7093 Intermediate Similarity NPC470069
0.7093 Intermediate Similarity NPC52059
0.7062 Intermediate Similarity NPC326575
0.7055 Intermediate Similarity NPC311330
0.7045 Intermediate Similarity NPC475097
0.7017 Intermediate Similarity NPC472209
0.7 Intermediate Similarity NPC474077
0.7 Intermediate Similarity NPC52801
0.6982 Remote Similarity NPC161827
0.6978 Remote Similarity NPC291759
0.6927 Remote Similarity NPC133261
0.6923 Remote Similarity NPC133591
0.6923 Remote Similarity NPC295478
0.6923 Remote Similarity NPC476095
0.6919 Remote Similarity NPC225319
0.6919 Remote Similarity NPC143457
0.6918 Remote Similarity NPC132847
0.6893 Remote Similarity NPC139085
0.6893 Remote Similarity NPC214626
0.6893 Remote Similarity NPC251212
0.6893 Remote Similarity NPC473743
0.6885 Remote Similarity NPC207033
0.6885 Remote Similarity NPC38823
0.6879 Remote Similarity NPC99632
0.6879 Remote Similarity NPC282339
0.6879 Remote Similarity NPC472117
0.6875 Remote Similarity NPC257354
0.6875 Remote Similarity NPC469915
0.6868 Remote Similarity NPC245741
0.6867 Remote Similarity NPC470579
0.6865 Remote Similarity NPC95783
0.6854 Remote Similarity NPC329688
0.6854 Remote Similarity NPC189812
0.6848 Remote Similarity NPC285841
0.6842 Remote Similarity NPC29285
0.6839 Remote Similarity NPC325013
0.6825 Remote Similarity NPC475559
0.6821 Remote Similarity NPC472102
0.6821 Remote Similarity NPC309531
0.6816 Remote Similarity NPC320147
0.6813 Remote Similarity NPC472104
0.6811 Remote Similarity NPC217294
0.6798 Remote Similarity NPC106593
0.6782 Remote Similarity NPC140311
0.6779 Remote Similarity NPC470550
0.6774 Remote Similarity NPC469470
0.6774 Remote Similarity NPC469501
0.6771 Remote Similarity NPC471512
0.6766 Remote Similarity NPC469735
0.6765 Remote Similarity NPC473667
0.6765 Remote Similarity NPC275839
0.6755 Remote Similarity NPC203972
0.6751 Remote Similarity NPC475422
0.674 Remote Similarity NPC218594
0.674 Remote Similarity NPC99043
0.6735 Remote Similarity NPC87755
0.6734 Remote Similarity NPC475602
0.6723 Remote Similarity NPC154293
0.6722 Remote Similarity NPC476441
0.6721 Remote Similarity NPC98197
0.672 Remote Similarity NPC221687
0.6709 Remote Similarity NPC197680
0.6709 Remote Similarity NPC259098
0.6708 Remote Similarity NPC64897
0.6708 Remote Similarity NPC90693
0.6706 Remote Similarity NPC206592
0.6704 Remote Similarity NPC472123
0.6703 Remote Similarity NPC282092
0.6688 Remote Similarity NPC278097
0.6686 Remote Similarity NPC114808
0.6684 Remote Similarity NPC231342
0.6667 Remote Similarity NPC13367
0.6649 Remote Similarity NPC28510
0.6649 Remote Similarity NPC90967
0.6649 Remote Similarity NPC302548
0.6648 Remote Similarity NPC126492
0.6648 Remote Similarity NPC469541
0.6648 Remote Similarity NPC158129
0.6647 Remote Similarity NPC217801
0.6632 Remote Similarity NPC475489
0.6632 Remote Similarity NPC79129
0.6632 Remote Similarity NPC249150
0.6632 Remote Similarity NPC81654
0.6632 Remote Similarity NPC195461
0.6632 Remote Similarity NPC49196
0.6632 Remote Similarity NPC313985
0.663 Remote Similarity NPC264482
0.663 Remote Similarity NPC203202
0.6629 Remote Similarity NPC81229
0.6629 Remote Similarity NPC255229
0.6627 Remote Similarity NPC469740
0.6626 Remote Similarity NPC175870
0.6615 Remote Similarity NPC477135
0.6612 Remote Similarity NPC15840
0.6611 Remote Similarity NPC96901
0.6609 Remote Similarity NPC113946
0.6609 Remote Similarity NPC104345
0.6607 Remote Similarity NPC237240
0.6607 Remote Similarity NPC31171
0.6605 Remote Similarity NPC184437
0.6597 Remote Similarity NPC473375
0.6597 Remote Similarity NPC97100
0.6593 Remote Similarity NPC260075
0.6593 Remote Similarity NPC211997
0.6591 Remote Similarity NPC176983
0.6591 Remote Similarity NPC85651
0.6587 Remote Similarity NPC473922
0.6584 Remote Similarity NPC42423
0.6578 Remote Similarity NPC181928
0.6573 Remote Similarity NPC98187
0.6561 Remote Similarity NPC470483
0.6556 Remote Similarity NPC205652
0.6552 Remote Similarity NPC473837
0.6552 Remote Similarity NPC10730
0.6552 Remote Similarity NPC10875
0.655 Remote Similarity NPC318086
0.6548 Remote Similarity NPC262216
0.6548 Remote Similarity NPC472111
0.6538 Remote Similarity NPC134586
0.6536 Remote Similarity NPC317430
0.6534 Remote Similarity NPC315368
0.6534 Remote Similarity NPC474058
0.6532 Remote Similarity NPC478076
0.6528 Remote Similarity NPC50503
0.6522 Remote Similarity NPC300688
0.6519 Remote Similarity NPC476425
0.6513 Remote Similarity NPC472329
0.6513 Remote Similarity NPC472330
0.6508 Remote Similarity NPC473298
0.6506 Remote Similarity NPC239770
0.6505 Remote Similarity NPC97584
0.6505 Remote Similarity NPC165201
0.6503 Remote Similarity NPC313352
0.6503 Remote Similarity NPC151939
0.65 Remote Similarity NPC126066
0.65 Remote Similarity NPC40488
0.6492 Remote Similarity NPC470485
0.6491 Remote Similarity NPC201692
0.6489 Remote Similarity NPC119700
0.6488 Remote Similarity NPC223590
0.6486 Remote Similarity NPC302191
0.648 Remote Similarity NPC472115
0.648 Remote Similarity NPC19555
0.648 Remote Similarity NPC472114
0.6477 Remote Similarity NPC235460
0.6477 Remote Similarity NPC162440
0.6477 Remote Similarity NPC291359
0.6474 Remote Similarity NPC472097
0.6474 Remote Similarity NPC25401
0.6471 Remote Similarity NPC173934

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC477156 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7439 Intermediate Similarity NPD4120 Approved
0.7439 Intermediate Similarity NPD4121 Phase 3
0.7394 Intermediate Similarity NPD5743 Approved
0.7394 Intermediate Similarity NPD5741 Approved
0.7394 Intermediate Similarity NPD5742 Approved
0.723 Intermediate Similarity NPD2212 Approved
0.723 Intermediate Similarity NPD2210 Approved
0.7222 Intermediate Similarity NPD5595 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD6789 Approved
0.7091 Intermediate Similarity NPD5881 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD6606 Clinical (unspecified phase)
0.6939 Remote Similarity NPD3149 Approved
0.6939 Remote Similarity NPD2659 Approved
0.6939 Remote Similarity NPD3150 Approved
0.6939 Remote Similarity NPD3147 Approved
0.6939 Remote Similarity NPD2658 Approved
0.6939 Remote Similarity NPD3148 Approved
0.691 Remote Similarity NPD6375 Clinical (unspecified phase)
0.6906 Remote Similarity NPD7252 Clinical (unspecified phase)
0.6871 Remote Similarity NPD1764 Approved
0.6871 Remote Similarity NPD1762 Approved
0.6867 Remote Similarity NPD7522 Discontinued
0.6848 Remote Similarity NPD4951 Discontinued
0.6813 Remote Similarity NPD5522 Clinical (unspecified phase)
0.681 Remote Similarity NPD6522 Clinical (unspecified phase)
0.6805 Remote Similarity NPD3329 Clinical (unspecified phase)
0.679 Remote Similarity NPD3864 Clinical (unspecified phase)
0.6788 Remote Similarity NPD6301 Phase 2
0.6779 Remote Similarity NPD5631 Phase 3
0.676 Remote Similarity NPD5602 Clinical (unspecified phase)
0.6747 Remote Similarity NPD6506 Clinical (unspecified phase)
0.6744 Remote Similarity NPD6026 Approved
0.6709 Remote Similarity NPD4895 Clinical (unspecified phase)
0.6685 Remote Similarity NPD7474 Suspended
0.6667 Remote Similarity NPD2174 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6316 Clinical (unspecified phase)
0.6649 Remote Similarity NPD5721 Clinical (unspecified phase)
0.6632 Remote Similarity NPD4600 Approved
0.6632 Remote Similarity NPD4601 Approved
0.663 Remote Similarity NPD8658 Clinical (unspecified phase)
0.6623 Remote Similarity NPD2622 Approved
0.6611 Remote Similarity NPD7418 Discontinued
0.6607 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6603 Remote Similarity NPD7461 Approved
0.6599 Remote Similarity NPD2679 Approved
0.6599 Remote Similarity NPD2678 Approved
0.6592 Remote Similarity NPD3051 Approved
0.658 Remote Similarity NPD6661 Clinical (unspecified phase)
0.6561 Remote Similarity NPD6025 Phase 1
0.6543 Remote Similarity NPD8118 Discontinued
0.6536 Remote Similarity NPD4986 Clinical (unspecified phase)
0.6534 Remote Similarity NPD7600 Phase 2
0.6528 Remote Similarity NPD7889 Clinical (unspecified phase)
0.6522 Remote Similarity NPD1001 Discontinued
0.6519 Remote Similarity NPD6320 Approved
0.6509 Remote Similarity NPD7295 Approved
0.6503 Remote Similarity NPD5185 Approved
0.6503 Remote Similarity NPD5182 Approved
0.6503 Remote Similarity NPD5184 Approved
0.6503 Remote Similarity NPD7200 Approved
0.65 Remote Similarity NPD7795 Phase 2
0.6474 Remote Similarity NPD6656 Clinical (unspecified phase)
0.6464 Remote Similarity NPD2970 Approved
0.6464 Remote Similarity NPD2969 Approved
0.6461 Remote Similarity NPD6635 Approved
0.646 Remote Similarity NPD2606 Approved
0.646 Remote Similarity NPD3595 Approved
0.646 Remote Similarity NPD3594 Approved
0.646 Remote Similarity NPD2605 Approved
0.6457 Remote Similarity NPD2789 Approved
0.6453 Remote Similarity NPD6222 Approved
0.6453 Remote Similarity NPD6221 Approved
0.6444 Remote Similarity NPD4639 Approved
0.6444 Remote Similarity NPD4640 Approved
0.6444 Remote Similarity NPD4638 Approved
0.6441 Remote Similarity NPD5599 Discontinued
0.6441 Remote Similarity NPD6524 Clinical (unspecified phase)
0.6425 Remote Similarity NPD5744 Clinical (unspecified phase)
0.6421 Remote Similarity NPD6281 Approved
0.642 Remote Similarity NPD5155 Approved
0.642 Remote Similarity NPD5156 Approved
0.6419 Remote Similarity NPD6038 Clinical (unspecified phase)
0.6416 Remote Similarity NPD6575 Clinical (unspecified phase)
0.6398 Remote Similarity NPD995 Clinical (unspecified phase)
0.6398 Remote Similarity NPD3637 Approved
0.6398 Remote Similarity NPD3635 Approved
0.6398 Remote Similarity NPD3636 Approved
0.6392 Remote Similarity NPD478 Approved
0.6384 Remote Similarity NPD7599 Phase 2
0.6379 Remote Similarity NPD8401 Approved
0.6379 Remote Similarity NPD6158 Phase 2
0.6379 Remote Similarity NPD6476 Clinical (unspecified phase)
0.6379 Remote Similarity NPD8400 Approved
0.6379 Remote Similarity NPD8402 Approved
0.6379 Remote Similarity NPD6707 Clinical (unspecified phase)
0.6378 Remote Similarity NPD7479 Phase 2
0.6368 Remote Similarity NPD7234 Approved
0.6368 Remote Similarity NPD7233 Approved
0.6358 Remote Similarity NPD6359 Clinical (unspecified phase)
0.6354 Remote Similarity NPD5862 Discovery
0.6353 Remote Similarity NPD7487 Discontinued
0.6339 Remote Similarity NPD2489 Approved
0.6339 Remote Similarity NPD27 Approved
0.6337 Remote Similarity NPD7794 Clinical (unspecified phase)
0.6335 Remote Similarity NPD2843 Phase 2
0.6335 Remote Similarity NPD2845 Phase 2
0.6329 Remote Similarity NPD7462 Clinical (unspecified phase)
0.6329 Remote Similarity NPD2173 Clinical (unspecified phase)
0.6328 Remote Similarity NPD5715 Clinical (unspecified phase)
0.6319 Remote Similarity NPD4274 Approved
0.6319 Remote Similarity NPD3720 Discontinued
0.6319 Remote Similarity NPD4275 Approved
0.6316 Remote Similarity NPD7785 Clinical (unspecified phase)
0.6316 Remote Similarity NPD8021 Approved
0.6316 Remote Similarity NPD8020 Approved
0.6316 Remote Similarity NPD8131 Suspended
0.6312 Remote Similarity NPD5578 Approved
0.6312 Remote Similarity NPD5577 Clinical (unspecified phase)
0.6308 Remote Similarity NPD6284 Clinical (unspecified phase)
0.6307 Remote Similarity NPD7969 Clinical (unspecified phase)
0.6307 Remote Similarity NPD5617 Suspended
0.6306 Remote Similarity NPD7725 Approved
0.6305 Remote Similarity NPD5936 Approved
0.6305 Remote Similarity NPD5939 Approved
0.6296 Remote Similarity NPD6227 Discontinued
0.6294 Remote Similarity NPD7082 Approved
0.6292 Remote Similarity NPD6060 Clinical (unspecified phase)
0.6289 Remote Similarity NPD3623 Clinical (unspecified phase)
0.6289 Remote Similarity NPD3622 Clinical (unspecified phase)
0.6286 Remote Similarity NPD2882 Phase 1
0.6284 Remote Similarity NPD5934 Clinical (unspecified phase)
0.6284 Remote Similarity NPD2216 Approved
0.6284 Remote Similarity NPD2215 Approved
0.628 Remote Similarity NPD8109 Clinical (unspecified phase)
0.6277 Remote Similarity NPD5596 Phase 2
0.6277 Remote Similarity NPD7962 Phase 2
0.6272 Remote Similarity NPD4726 Approved
0.6272 Remote Similarity NPD4721 Approved
0.6272 Remote Similarity NPD4725 Approved
0.6271 Remote Similarity NPD2527 Approved
0.6259 Remote Similarity NPD2244 Clinical (unspecified phase)
0.6257 Remote Similarity NPD7259 Approved
0.6257 Remote Similarity NPD6879 Phase 2
0.6257 Remote Similarity NPD6878 Phase 2
0.625 Remote Similarity NPD2038 Approved
0.625 Remote Similarity NPD7593 Clinical (unspecified phase)
0.625 Remote Similarity NPD5811 Approved
0.625 Remote Similarity NPD8354 Approved
0.625 Remote Similarity NPD2039 Approved
0.625 Remote Similarity NPD6607 Clinical (unspecified phase)
0.625 Remote Similarity NPD8063 Discontinued
0.6244 Remote Similarity NPD2177 Approved
0.6244 Remote Similarity NPD2176 Approved
0.6244 Remote Similarity NPD2175 Phase 3
0.6243 Remote Similarity NPD2421 Approved
0.6243 Remote Similarity NPD2420 Approved
0.6237 Remote Similarity NPD8006 Clinical (unspecified phase)
0.6236 Remote Similarity NPD4670 Clinical (unspecified phase)
0.6236 Remote Similarity NPD4671 Clinical (unspecified phase)
0.6236 Remote Similarity NPD4669 Clinical (unspecified phase)
0.623 Remote Similarity NPD2383 Phase 1
0.6229 Remote Similarity NPD8355 Approved
0.6229 Remote Similarity NPD8353 Approved
0.6228 Remote Similarity NPD6544 Discontinued
0.6225 Remote Similarity NPD1108 Approved
0.6225 Remote Similarity NPD4116 Approved
0.6225 Remote Similarity NPD1107 Approved
0.6221 Remote Similarity NPD8323 Discontinued
0.6218 Remote Similarity NPD6630 Clinical (unspecified phase)
0.6218 Remote Similarity NPD5912 Clinical (unspecified phase)
0.6218 Remote Similarity NPD5913 Phase 3
0.6211 Remote Similarity NPD1036 Approved
0.6207 Remote Similarity NPD4702 Approved
0.6207 Remote Similarity NPD4703 Approved
0.6207 Remote Similarity NPD4682 Phase 2
0.6205 Remote Similarity NPD3109 Approved
0.6205 Remote Similarity NPD3110 Approved
0.6203 Remote Similarity NPD4076 Approved
0.6203 Remote Similarity NPD4079 Approved
0.62 Remote Similarity NPD2243 Clinical (unspecified phase)
0.6197 Remote Similarity NPD6978 Phase 2
0.6197 Remote Similarity NPD6977 Clinical (unspecified phase)
0.6196 Remote Similarity NPD3975 Discontinued
0.6196 Remote Similarity NPD7582 Discontinued
0.6193 Remote Similarity NPD7836 Clinical (unspecified phase)
0.6193 Remote Similarity NPD2188 Approved
0.619 Remote Similarity NPD1419 Approved
0.619 Remote Similarity NPD4719 Phase 2
0.619 Remote Similarity NPD7883 Discontinued
0.619 Remote Similarity NPD1417 Approved
0.6183 Remote Similarity NPD2382 Approved
0.6183 Remote Similarity NPD2380 Approved
0.6183 Remote Similarity NPD2381 Approved
0.6183 Remote Similarity NPD5100 Phase 3
0.6182 Remote Similarity NPD864 Approved
0.6182 Remote Similarity NPD865 Approved
0.6179 Remote Similarity NPD6976 Clinical (unspecified phase)
0.6173 Remote Similarity NPD6900 Discontinued
0.6171 Remote Similarity NPD1405 Approved
0.617 Remote Similarity NPD6833 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data